Publications by authors named "William R Moore"

Claim this Profile
P
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment.
Ravi A Madan, Keith T Schmidt, Fatima Karzai, Cody J Peer, Lisa M Cordes, William R Moore

Clin Genitourin Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer.
John D Norris, Stephanie J Ellison, Jennifer G Baker, David B Stagg, Suzanne E Wardell, William R Moore

J Clin Invest· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of highly-selective fungal CYP51 inhibitors.
William J Hoekstra, Edward P Garvey, William R Moore, Stephen W Rafferty, Christopher M Yates

Bioorg Med Chem Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors.
Stephen W Rafferty, Joel R Eisner, William R Moore, Robert J Schotzinger, William J Hoekstra

Bioorg Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agent.
Rupa S Shetty, Younghee Lee, Bin Liu, Arifa Husain, Rhoda W Joseph, William R Moore

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early prosthetic complications after unipolar hemiarthroplasty.
Patrick C L Weinrauch, William R Moore, David R Shooter, Matthew P R Wilkinson, Esther M Bonrath

ANZ J Surg· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing discovery efficiency with a computationally driven fragment approach.
William R Moore

Curr Opin Drug Discov Devel· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 21,21-difluoro-3 beta-hydroxy-20-methylpregna-5,20-diene and 5,16,20-triene as potential inhibitors of steroid C17(20) lyase.
Philip M Weintraub, Amy K Holland, Cynthia A Gates, William R Moore, Robert J Resvick

Bioorg Med Chem· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis